News
Sigma1 Pharmacology in the Context of Cancer
Kim, FJ and Maher, CM. Handbook of Experimental Pharmacology.
Researchers at Sidney Kimmel Cancer Center at Thomas Jefferson University Promise New Directions for Targeting Prostate Cancer
A team of Sidney Kimmel Cancer Center (SKCC) investigators from Thomas Jefferson University and Drexel University has recently published a new study in the journal Cancer Research that sheds light on a key mechanism of prostate cancer progression.
Novel Small Molecule Sigma1 Inhibitors for Advanced Prostate Cancer
Salvino, JS, Oyer, HM, Kim, FJ, et al. Bioorganic & Medicinal Chemistry Letters.